TRAUMATIC NERVE INJURY
eration may improve the functional recovery. Besides postsurgical electric stimulation (25, 38) , transplantation of regeneration-promoting glia is promising approach to Peripheral nerve injury associated with trauma is a common and devastating complication that can cause ir-accelerate the regenerative process (58, 61) . If the proximal end of the disrupted nerve is blocked reversible impairment and complete functional loss of the affected limb. Axonal regeneration and functional from the peripheral target associated with the distal stump, sprouting axons do not find the correct way, recovery may occur after surgical reapposition, but the clinical outcome is often not optimal. Important factors which results in aberrant axonal growth within the proximal stump (1, 38) , leading to neuroma formation associ-contributing to the poor functional recovery are the localization of the lesion site and the delay in nerve repair ated with pain and dysesthesia (14) . Achieving optimal regrowth into the distal stump is, therefore, not only es- (19) . It was shown that prolonged target deprivation reduces the capacity of injured motoneurons to regenerate sential for gaining functional recovery, but also to prevent the potentially devastating sensory hyperexcitabil-(21). Chronic denervated Schwann cells are known to display reduced regenerative capacity (75). Thus, any ity associated with neuroma formation. Besides the correct reinnervation of the original targets (e.g., muscle therapeutical treatments that accelerate axonal regen-146 RADTKE ET AL. or sensory organs), axons also have to induce remyelina-olfactory neurons guide and promote their axons into and within the CNS. tion and proper formation of the nodes of Ranvier with appropriate clustering of sodium channels that allow Based on the observations that the olfactory system displays neurogenesis and entry of axonal processes into rapid impulse conduction. Transplantation of myelinforming cells into a nerve defect site has been shown to the central nervous system throughout life time, it was proposed that OECs display unique regenerative proper-facilitate this complex repair process (15, 56, 71, 72) .
Reapposition of transected nerve by surgical reappo-ties. In situ, OECs have been shown to share characteristics with both SCs and astrocytes (13). The majority of sition represents the current primary clinical approach to nerve repair. An early study evaluated the efficacy of investigations so far have used OECs harvested from the olfactory bulb (63) . However, OECs can also be pre-nerve coadaptation techniques and application of biological materials to nerve stumps to evaluate their role in pared from the nasal mucosa (35, 66) . Harvesting OECs from biopsies of the nasal mucosa is providing an easy promoting nerve regeneration (77) . It is well established that minimal tissue manipulation, attenuation of inflam-possibility of autologous transplantation and could reduce the risk of immunological rejection (51) . matory responses, and minimization of tension at suture sites are crucial for successful anastomosis of peripheral Gliotic tissue (produced by astrocytes) is an inhibitory substrate for axonal regeneration (47, 67, 70) . How-nerves (26). Extensive scar tissue formation at the lesion site that can lead to mechanical obstruction for axonal ever, OECs are permissive for regenerating axons and can navigate growing axons through the glial scar. Like regeneration and nerve conduction block may require surgical neurolysis.
SCs, OECs possess the ability to remove degenerating axons via phagocytosis (4, 39, 83) and can produce chan-Cell transplantation approaches are being used in experimental models of spinal cord and peripheral nerve nels along which newly formed axons can regenerate (40) . Thus, OECs have the ability to navigate glial scars injury to enhance nerve regeneration (61, 63) . The cell types subject to intense investigation include Schwann and have been shown to enhance axonal regeneration (67), thus utilizing a mechanism employed during em-cells (SCs) and olfactory ensheathing cells (OECs) either derived from the olfactory bulb or the olfactory mu-bryogenesis in the navigation of olfactory nerves to the olfactory bulb (65) . OECs, like SCs, have been shown cosa, stromal cells from bone marrow (mesenchymal stem cells, MSCs), or adipose tissue-derived cells (60) .
to synthesize a number of neurotrophic factors, such as nerve growth factor, brain-derived neurotrophic factor OECs are specialized glial cells of the olfactory system that are of particular interest in this context (63) . OECs (BDNF), and ciliary neurotrophic factor (51,71,82), platelet-derived growth factor, and neuropeptide Y (78), do not only reside in both the peripheral nervous system (PNS) and the CNS under normal conditions, but they suggesting that trophic factor production by OECs might enhance the survival and promote regeneration of dam-have also been shown to promote neural regeneration in a variety of different lesion paradigms. Although ini-aged axons. While OECs normally do not form myelin in the olfactory system, they can produce myelin after tially used for promoting central regeneration, it has become apparent in the recent years that OECs may also transplantation into demyelinated lesions of the PNS and CNS (18, 34, 56) . promote PNS regeneration (56, 79) . In this review, we will focus on the potential of OECs for improving regen-
The mature PNS generally shows a better regeneration of injured axons compared to the CNS. But com-eration when used as an adjunct to peripheral nerve suture repair.
plete functional recovery is rarely achieved because aberrant reinnervation frequently occurs due to extensive OECs DISPLAY SPECIAL branching of regrowing axons. This might be even in REGENERATION-PROMOTING PROPERTIES case of morphologically good axonal regeneration (11) . Facial synkinesis has been described as a pathological Olfactory epithelial neurons in the nasal mucosa are continuously replaced by progenitor cells and send their consequence of aberrant reinnervation (3). Reduction of hyperinnervation and precisely directed target reinnerva-axons across the PNS-CNS boundary into the olfactory bulbs even in the adult (27, 52) . Olfactory nerve transec-tion is an important aim of therapeutic interventions in peripheral nerve repair and might include the application tion leads to acceleration of olfactory epithelial neuron differentiation in the olfactory epithelium (9) . OECs are of antagonizing molecular factors like neutralizing antibodies or treatment with cells secreting neurotrophic fac-glia cells located in the olfactory mucosa, olfactory nerve, and the outer nerve layer of the olfactory bulb tors, although major progress has still to be achieved (2) . After nerve injury, fibroblasts are known to invade (64) . The lifelong neurogenesis of olfactory receptor neurons and the entry of their axons together with the the lesion site and producing scar tissue that is a mechanical barrier to axonal growth across the lesion site. well-established role of glial cells in axon growth were the basis to propose that OECs closely associated with This is one factor that contributes to the reduced func-tional outcome. Scar tissue is thought to impede the mi-provide trophic factors and directional cues (12,15,56). OECs were initially transplanted to the transected pe-gration not only of regenerating axons but also of migrating SCs that support regeneration. Although adequate ripheral nerve by Verdu et al. (79) and shown to promote axonal growth across a 15-mm gap. Engraftment studies that compare the effects of SCs and OECs are still low in number (81, 84) , experimental evidence sug-of OECs into the axotomized facial nerve produced controversial results. Whereas axonal sprouting-promoting gests that OECs but not SCs are able to cross the lesion site (18, 42) . OECs have a greater migratory potential effects of OECs were initially reported (12,28), reinvestigation by Angelov et al. (2) revealed no significant than SCs (39, 41, 67) and they produce neurotrophic factors (82). Furthermore, OECs do not accumulate proteo-alterations in axonal sprouting by transplanted OECs. This is in line with a study by Choi and Raisman (11) glycans, which cause growth cone collapse (5, 55) , as do SCs. Therefore, OECs may be a suitable candidate for that reported no OEC-induced effects on the aberrant sprouting but an increase in the eye closure rate. Inter-cell-based regenerative therapies. Clinical trials have been initiated using OECs to repair spinal cord lesions estingly, transplantation of olfactory mucosa explants in the same lesion model minimized axonal branching and in humans (16, 31, 46, 50) and to improve functional outcome after cerebral palsy in adolescence and children (10) .
promoted the functional recovery of vibrissae movements (29).
TRANSPLANTATION OF OECs
Previously, we reported that both SCs (57) and OECs IN PERIPHERAL NERVE REPAIR (15) transplanted into the transected sciatic nerve invaded the injury site and formed peripheral type myelin The PNS is generally considered a permissive environment with respect to neurite growth (20, 24) . This is, with correct clustering of sodium channels (Nav1.6). Moreover, engrafted OECs were found to accelerate and at least in part, due to the low levels of myelin-associated growth inhibitory molecules that are abundant in improve functional recovery following nerve injury (33) . OECs transplanted in the adult rat sciatic nerve at the the CNS (7) . Another important consideration for successful peripheral nerve regeneration is the presence of time of microsurgical intervention, improved both axonal regeneration and the functional outcome, as mea-SCs. In the PNS, SCs in the distal segment of a cut nerve dissociate from the degenerating axons, upregulate sured by the sciatic functional index (SFI) (56) . Interestingly, we noted a significantly reduced die-back of the expression of nerve growth factor (NGF) and its low affinity receptor , the neurotrophin receptor p75 (p75 NTR ) axons proximal to the transection site as well as an increased number of regenerated axons in the distal nerve (37) . Axons in the proximal nerve stump initiate sprouting and regeneration through SC-enriched basal lamina stump. The microsutured nerves lacking OECs displayed a thinner caliber (i.e., constricted) at the repair site than tubes prior to reestablishing functional connections to peripheral targets such as skin and muscle under optimal nerves that received OEC transplants (56) . This may suggest that the transplanted OECs were primed to pro-conditions with varying degrees of functional recovery. A number of issues, such as the delayed expression of duce neurotrophins, such as NGF, and, therefore, provided immediate trophic support to the injured axons. NGF and p75 NTR , the dying back of the injured axons, the navigation of axons across the lesion site, and the This may provide an explanation for reduced axonal dieback and the accelerated regeneration rate of the injured appropriate targeting to peripheral end structures are major clinical concerns.
axons. Usually, axons die-back a couple of millimeter after nerve transection and with a delay of a several The prototype lesion paradigm used to determine axon growth-promoting properties of OECs is the dorsal days; axonal growth rate is not higher than 1-2 mm per day. OECs, therefore, may be a tool to reduce this delay root rhizotomy of adult rat (Table 1) . However, whereas early in vivo studies reported facilitated entry of periph-and to promote axonal growth across the injury site well before significant scar tissue is formed. eral sensory dorsal root ganglionic neurons by transplantation of OECs (53,67), recent studies failed to demon-CHALLENGES IN CELL THERAPY APPROACHES strate similar effects (23, 66, 69) . The reason for these FOR PERIPHERAL NERVE REPAIR discrepancies still has to be clarified. Recently, Li et al.
(44) reported beneficial effects of transplanted OECs to
Harvesting sufficient numbers of cells is an important concern with regard to cell transplantation therapies. In the reanastomosed ventral S1 root. Very recently, Ibrahim et al. (32) reported transplantation of OECs in a brachial the laboratory, several cell types can be expanded in culture using trophic factors and mitogens. However, in plexus injury model. Here, OECs increased regeneration at both the anatomical and functional level.
vitro cell expansion could alter the physiologic properties of the cells. Another concern with expanded cells is OECs have been considered as an adjunct for peripheral nerve repair because they may not only provide a the potential risk of tumor formation. It is essential to determine if experimental in vivo transplantation of ex-scaffold for regrowing axons but also because they could panded cells not only retained their ability to carry out The neurotrophin production of transplanted OECs may alter axonal sprouting and synapse formation. One neural repair, but also that the cells are not tumorigenic. With increased cell passages, the properties of expand-concern is that the newly organized neural structures could be maladaptive and elicit neurological problems ing oncogenic subclones increase and rigorous testing of the expanded cells is critical. It cannot be assumed that such as pain or allodynia (30) . Transplantation of NGFproducing keratinocytes into injured peripheral nerve observed safety in animal models will also apply to humans.
leads to extreme hyperexcitability and pain (62) . Care must be taken to study functional properties of regener-mediated Cre recombinase delivery. At every investigated state as primary, immortalized, and deimmorta-ated axons and their parent cell bodies elicited by interventional approaches such as cell transplantation does lized cells maintained their phenotype characterized by S100, GFAP, vimentin, ErbB2 receptor, neuroligin-3, not result in maladaptive responses. Importantly, we found that nodal sodium channels are appropriate fol-APP, and nestin expression. Additionally, they were able to promote axonal regeneration of adult rat retinal lowing transplantation in injured nerve (15,57) and spinal cord (71). Design of functional experiments to assess ganglion neurons (RGN) in coculture assays (45). García-Escudero et al. investigated different combi-efficacy will be essential for evaluating these approaches in clinical studies. Along this line is the recent observa-nations of transduction with TERT and Bmi with SV40 large T antigen (TAg) and a short hairpin RNA directed tion that SC p75 NTR prevents spontaneous reinnervation of the adult spinal cord (74) . Contrary to the widely held against p53 (shp53). Neuroregenerative capacity was observed in all cell populations but the deimmortalzation view, these authors postulate that p75 NTR on glia may restrict the availability of NGF for neurons and recom-process was best tolerated in Bmi/TERT cells (22). In a comparative study, adult canine SCs and OECs mend to block p75 NTR expression on SCs and OECs prior to therapeutic application. In this context it is interesting were transfected with human TERT and analyzed with regard to antigenic expression and growth rates. No sig-to note that adult canine OECs in vitro display significantly lower levels of p75 NTR than SCs (Techangamsu-nificant differences between both cell types were demonstrated underscoring the close relationship between wan, unpublished observation).
Another challenge is the time delay that currently is the two cell types (76). Ectopic expression of TERT allowed escape from growth arrest without changing the required for preparation of OECs if they are prepared from biopsy of nasal mucosa. However, these autolo-cellular phenotype. Interestingly, late passage cells maintained constant proliferation rates only in the presence gous sources of cells would require days in culture for preparation and thus a critical therapeutic window could of fibroblast growth factor-2 (FGF-2) (76). be missed. The development of immunologically com-COMBINATORIAL THERAPIES patible cells that could be produced in high quantity and banked for later use is a critical experimental challenge.
Treatment of peripheral nerve injury may require the development of combinatorial strategies promoting neu-OECs derived from porcine olfactory bulb show poor survival in long-term culture and lose their ability to my-roprotection (pharmacological blockade of secondary damage), axonal regeneration (electrical stimulation, cell elinate axons after a few weeks in culture (59) .
Although cell transplantation is a promising option transplantation combined with genetic engineering aiming to modulate trophic factor and/or growth inhibitory for current and future clinical use, there are natural restrictions regarding cell sources and in vitro expansion molecules, minimized scar formation), and rehabilitation as proposed for the CNS (8) . OECs have been reported that are still a major challenge to the development of autologous cell transplantation. Research focuses on two to promote neuroprotection of spinal cord parenchyma at least in part by modulating the expression of COX-2 major directions to overcome this limitation: immortalization of primary cells, allowing indefinite expansion, and iNOS (48) . OECs have been shown to reduce loss of corticospinal tract neurons after spinal cord transection and reprogramming of somatic cells to generate large numbers of pluripotent stem cells. Both techniques largely de-possibly by production of BDNF (71). Moreover, transplantation of MSCs genetically modified to produce pend on genetic modifications often making use of viral transductions.
BDNF has neuronal protective effects in this model system (73) . It was recently demonstrated that genetically Immortalization of primary cells is frequently achieved by circumventing cellular senescence. This is typically modified OECs were capable of surviving and producing NT-3 in vivo and to significantly improve locomotor done by preventing the progressive telomere shortening via telomerase reverse transcriptase (TERT) (85) alone functional recovery after spinal cord injury (49) . OECs can remyelinate regenerated and demyelinated axons. or in combination with factors stimulating cell growth.
In an approach to immortalize OECs from the human Thus, OECs may exert multiple therapeutic effects including neuroprotection, neurotrophism, and remyelina-olfactory bulb, transduction with lentivectors encoding Bmi-1 and TERT transgenes flanked by loxP sites was tion. Future research might look into effective combina-used (45). Polycomb group transcription factor Bmi-1 can inhibit growth-inhibitory functions of both p53 and tion strategies to improve functional outcome after injury. Combination therapies tested so far in the CNS Rb pathways, via its repressive effect on the Ink4a/Arf tumor suppressor locus (36) while it is alone not able to include the application of OECs together with SCs (54), with chondroitinase ABC or trophic factors, such as suppress telomere shortening. Importantly, this strategy allowed excision of the floxed transgenes by lentivector-BDNF, as well as the application of cyclic AMP level- 
